Results 181 to 190 of about 22,796,869 (307)
Analysing the Structural Identifiability and Observability of Mechanistic Models of Tumour Growth. [PDF]
González Vázquez A, Villaverde AF.
europepmc +1 more source
Mechanistic models to meet the challenge of climate change in plant-pathogen systems. [PDF]
Jiranek J +4 more
europepmc +1 more source
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié +16 more
wiley +1 more source
Visualizing mechanistic models by integrating site-specific molecular details into reaction networks. [PDF]
Vasilescu D +3 more
europepmc +1 more source
Mechanistic models of Rift Valley fever virus transmission: A systematic review. [PDF]
Cecilia H +6 more
europepmc +1 more source
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker +16 more
wiley +1 more source
Mechanistic models of asymmetric hand-over-hand translocation and nucleosome navigation by CMG helicase. [PDF]
Nagae F +4 more
europepmc +1 more source
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad +17 more
wiley +1 more source
In Vitro Models of Ovarian Cancer: Bridging the Gap between Pathophysiology and Mechanistic Models. [PDF]
Lopez E +8 more
europepmc +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source

